Patients in the very early stages of dementia could miss out on a potentially effective treatment after misleading research was published last year, say medical experts.The researchers, who claimed that B vitamins were ‘sadly not going to prevent Alzheimer’s disease‘1, have been strongly criticised.Clinicians and scientists have labelled the statement ‘inaccurate and misleading’, voicing concerns that the unjustified claim could bias research funding and health policy decisions, as well as having a negative impact on patient welfare.Dr Peter Garrard, of the Cardiovascular and Cell Sciences Research Institute at St George’s, University of London, said that the analysis of previous clinical trial data published last year cast no doubt whatever on the potential of folic acidand vitamin B-12 to prevent dementia, and that the lead author’s comments were ‘unjustified and misleading’.
Read the rest of the article at http://www.medicalnewstoday.com/releases/289766.php.
William M. Bennett, MD 